Melanocyte Transplantation Plus Topical JAK Inhibitor or Tacrolimus for Treatment of Vitiligo: A Randomized Comparative Study
On-Demand Video
Event Details
Skin of Color Society 20th Annual Skin of Color Society Scientific Symposium
Pathways to Equity: Advancing Advocacy, Research, and Clinical Excellence
Presented and recorded on March 7, 2024 in San Diego, CA
Non-CME
Lecture: Melanocyte Transplantation Plus Topical JAK Inhibitor or Tacrolimus for Treatment of Vitiligo: A Randomized Comparative Study
This meeting was planned and organized by the 2023-2024 SOCS Scientific Committee co-chaired by Drs. Nada Elbuluk and Chere Lucas Anthony. View Final Program.
Speaker
Maggi Ahmed, MD, PhD
Dermatology Resident
Department of Dermatology
University of Massachusetts Medical School
Dr. Ahmed is an internationally trained dermatology consultant who has made original contributions of major significance to the field. Her work has led to a greater understanding of surgical management of vitiligo and the immunological underpinnings for successful long-term surgical outcomes. She has successfully earned her clinical and translational PhD degree in dermatology, in surgical grafting of vitiligo, from the University of Massachusetts Medical School. Her areas of interest include procedural dermatology, Mohs surgery and laser. Dr. Ahmed’s work has developed cutting-edge surgical treatments for patients with pigmentary skin disorders. Due to the significant impact of her work, she received the Skin of Color Society Research Grant Award, among other awards. Her original findings have appeared in leading, peer-reviewed journals in the field. Dr. Ahmed is an editorial reviewer for multiple national and international dermatology journals.